A detailed history of Janiczek Wealth Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Janiczek Wealth Management, LLC holds 6,728 shares of NVO stock, worth $714,042. This represents 0.2% of its overall portfolio holdings.

Number of Shares
6,728
Previous 6,438 4.5%
Holding current value
$714,042
Previous $826,000 16.22%
% of portfolio
0.2%
Previous 0.18%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$122.71 - $146.91 $35,585 - $42,603
290 Added 4.5%
6,728 $960,000
Q1 2024

Apr 15, 2024

BUY
$102.11 - $135.92 $58,815 - $78,289
576 Added 9.83%
6,438 $826,000
Q4 2023

Jan 26, 2024

BUY
$87.78 - $105.45 $12,552 - $15,079
143 Added 2.5%
5,862 $606,000
Q3 2023

Oct 13, 2023

BUY
$90.94 - $199.54 $264,089 - $579,464
2,904 Added 103.16%
5,719 $520,000
Q2 2023

Jul 11, 2023

BUY
$155.98 - $172.65 $8,110 - $8,977
52 Added 1.88%
2,815 $455,000
Q1 2023

Apr 21, 2023

SELL
$132.34 - $159.14 $2,382 - $2,864
-18 Reduced 0.65%
2,763 $439,000
Q4 2022

Jan 20, 2023

BUY
$102.55 - $135.33 $9,742 - $12,856
95 Added 3.54%
2,781 $0
Q3 2022

Oct 17, 2022

SELL
$95.28 - $116.93 $14,196 - $17,422
-149 Reduced 5.26%
2,686 $279,000
Q2 2022

Aug 03, 2022

SELL
$103.24 - $121.81 $27,978 - $33,010
-271 Reduced 8.73%
2,835 $329,000
Q1 2022

May 05, 2022

BUY
$93.1 - $112.54 $30,071 - $36,350
323 Added 11.61%
3,106 $345,000
Q4 2021

Feb 02, 2022

BUY
$95.88 - $117.08 $14,477 - $17,679
151 Added 5.74%
2,783 $312,000
Q3 2021

Oct 19, 2021

BUY
$84.42 - $106.62 $15,448 - $19,511
183 Added 7.47%
2,632 $253,000
Q2 2021

Jul 28, 2021

BUY
$67.66 - $84.76 $1,353 - $1,695
20 Added 0.82%
2,449 $205,000
Q1 2021

Apr 28, 2021

BUY
$67.06 - $75.82 $60,756 - $68,692
906 Added 59.49%
2,429 $164,000
Q4 2020

Jan 26, 2021

BUY
$63.89 - $73.8 $56,350 - $65,091
882 Added 137.6%
1,523 $106,000
Q3 2020

Oct 19, 2020

BUY
$63.69 - $70.22 $40,825 - $45,011
641 New
641 $45,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $240B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Janiczek Wealth Management, LLC Portfolio

Follow Janiczek Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janiczek Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janiczek Wealth Management, LLC with notifications on news.